PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
March 19, 2026iMeta2 citationsOpen Access

Spatial multi‐omics identifies a NOTCH3‐mediated capillary–mCAF crosstalk driving immune exclusion in hepatocellular carcinoma

View Full Paper
FJFansen JiHLHaochen LiQWQ. Wang

Key Points

  • This study aims to explore the role of NOTCH signaling in capillary and cancer-associated fibroblast communication in hepatocellular carcinoma.
  • Utilized spatial multi-omics data from hepatocellular carcinoma samples.
  • Integrated single-cell RNA sequencing profiles of cancer-associated fibroblasts.
  • Investigated the effects of NOTCH signaling perturbation on T cell infiltration in vitro and in mouse models.
  • Identified DLL4-NOTCH3 signaling's role in polarizing cancer-associated fibroblasts.
  • Observed that perturbing NOTCH signaling increased T cell infiltration.
  • Found improved immunotherapy response in models with altered NOTCH signaling.

Abstract

Abstract Fibrosis induced immune exclusion is a hepatocellular carcinoma (HCC) hallmark, underscoring the key role of cancer‐associated fibroblasts (CAFs) in immune regulation. Through HCC spatial multi‐omics data and integrating pan‐cancer scRNA‐seq profiles of CAFs under immune checkpoint blockade (ICB) treatment, we characterized a potential crosstalk between capillaries and CAFs mediated by the NOTCH signaling pathway. Specifically, endothelial DLL4‐NOTCH3 signaling appears to be associated with matrix‐producing CAFs (mCAFs) polarization, leading to extracellular matrix remodeling and the establishment of immune‐restrictive niches that hinder T cell infiltration. Perturbation of NOTCH signaling attenuated mCAF differentiation and enhanced T cell infiltration in vitro, and was associated with improved ICB response in both spontaneous and orthotopic HCC mouse models. Collectively, our findings suggest that capillary‐mCAFs communication through the NOTCH pathway, particularly NOTCH3 activation, may contribute to fibrosis‐driven immune exclusion in HCC. Targeting this axis could provide a promising strategy to alleviate stromal barriers and potentiate immunotherapy efficacy.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Ji et al. (2026) studied this question.

synapsesocial.com/papers/69bb9357496e729e6298172ehttps://doi.org/10.1002/imt2.70117
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Targeting tumor-associated macrophage-derived CD74 improves efficacy of neoadjuvant chemotherapy in combination with PD-1 blockade for cervical cancer2024 · 44 citations
  2. 2USP14 governs CYP2E1 to promote nonalcoholic fatty liver disease through deubiquitination and stabilization of HSP90AA12023 · 50 citations
  3. 3Integrated Proteogenomic Characterization of HBV-Related Hepatocellular Carcinoma2019 · 1,187 citations
  4. 4A Targetable Molecular Chaperone Hsp27 Confers Aggressiveness in Hepatocellular Carcinoma2016 · 73 citations
  5. 5Osr2 functions as a biomechanical checkpoint to aggravate CD8+ T cell exhaustion in tumor2024 · 195 citations